Skip to content
OpenCapital
Get started

Baxter International BAX Medical Products & Therapies — Currency translation

Other segment segments

Pharmaceuticals
-$8M-147%
Healthcare Systems & Technologies
-$5M-163%

Similar metrics at other companies

Agilent Technologies logo
ALife Sciences and Applied Markets — Foreign currency translation impact
$1M0.0%
Cognizant logo
CTSHProducts and Resources — Foreign currency translation adjustments
$12.5M+261%
Nordson logo
NDSNMedical and Fluid Solutions — Currency effect
$1.16M+160%
Medtronic logo
MDTReportable Segments — Currency translation and other
$73.75M-54.1%
Aflac logo
AFLMedical and other health — Foreign currency translation
-$452M-136%
Cognizant logo
CTSHHealthcare — Foreign currency translation adjustments
-$2M-173%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's medical products & therapies — currency translation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's medical products & therapies — currency translation?
Baxter International (BAX) reported medical products & therapies — currency translation of -$17M in Q1 2026.
How has Baxter International's medical products & therapies — currency translation changed year-over-year?
Baxter International's medical products & therapies — currency translation decreased by 144.7% year-over-year, from $38M to -$17M.
What does medical products & therapies — currency translation mean?
The financial impact of changing currency exchange rates on this segment's reported earnings.
How do you interpret medical products & therapies — currency translation?
Positive values indicate a tailwind from currency movements, while negative values indicate a headwind.
How does medical products & therapies — currency translation compare across companies?
Commonly reported by multinational healthcare companies with significant non-domestic operations.